Credit Suisse High Income Fund Class A (MM) (CHIAX) Quote

PE for generic companies

From ChatGPT:
The average price-to-earnings (P/E) ratio for generic pharmaceutical companies as of 2024 is around 14.79. This value can fluctuate depending on specific market conditions, investor sentiment, and company performance within the sector. For

***** Triples zeros hitting now for MJNA junk stinky otc pinky - whoops

ENOUGH SAID

Ahhhh. A warning.

Is that why the corrupt Georgia court doesn't want to hand count the ballots in Georgia? So they can flip the vote?

NS, I didn’t either but it was in Hikma’s H1 2024 results filing - last paragraph in this link:

https://www.hikma.com/media/ul4ifnxb/2024-interim-press-release-vfinal-combined.pdf

This post from OCT 19 2023 is right on target

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173055987


News and updates in 2024 will verify that Joint venture in India will make international sales a very real thing.

Vietnam next ?

Probably his own DD. Don't see this report on any firm.

but the information could hardly be considered surprising...

It isn't surprising that Israel is planning an attack. But for Iran to have access to the IDF's specific plans would give them quite an advantage.

Looks like you nailed it. Could be a big week next week.

your mathing isn't exactly making you look smart....

Israeli media reports Netanyahu BLOCKED every cease fire deal -- and is continuing to do so.

Why?

Because he's made a SECRET DEAL WITH TRUMP to keep the war going, to help Trump get elected -- per PBS.

Dunno about that, but it could be true in the short t

I wouldn't be sure, but it wouldn't be about pro or against, it would be about the conflict and continuance of that conflict, about projectionism and blame, and things the republicans could use and do theatrical "inquiries" and "investigations" with. Geopolitical power struggles, arms sales, classi

IFUS due diligence has been consistently accurate

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173055913


IFUS STRONG

This is how they treated their own kids!

Imagine how nice they'd be to strangers on a dark street!

One year ago pantherj said new scientific information would help IFUS pps..


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173047171



He knows IFUS pps is heading upward again..Yet he lied again last week when he said IFUS would be

Hi $DUTV Team….i have a Riddle for you all to help me answer:



What do you call a sales rep that works for you for 6 months,

only makes TWO face to face sales calls during that ENTIRE time,

AND DOESN’T EVEN SELL 1 CENT OF PRODUCT?

My thought is slide back to 12-15 then move to 21-25. Dip again then about 20%up. Never straight unless flooring news

Elon Musk and Marjorie Taylor Greene risk Dominion’s wrath with revived conspiracy theories

Yes indeed! If I were Dominion, I'd be ready to file against Must bright and early Monday morning. But perhaps they're giving him more rope.

And an action against MTG would be e

TCI1, I didn't know that Amarin had requested injunctive relief in this suit.
This is going to be interesting as it plays out. The generic drug industry has quite a bit riding on this.
Sleven,

Spartan is well known but tell me where we can buy this compression. Can anyone buy it? I don’t see it anywhere.

No generic only company has P/E in the range of 30-35. The reason Elite's current PE of 25 is not over doing it is because that PE does NOT reflect a billion dollars of potential revenue that will be flowing Elite's say. Because of this cut the price range in half from $5 to $7 to $2.50 to $3.50.

If you are talking about the money you “invested” on BIOAQ then you have no money here. You know that though.

What happened to the fake X account? lol that didn’t last long.

Ex said: “NICE clearly states they expect the process to start prior to approval so they can act on it in time to provide an opinion shortly after approval.”


Apparently you don’t fully understand the process Ex. Funny, I thought you did.

Instead,

🌐 $ILLR Big things ahead! AGBA and @Triller's collaboration will lead the way in financial services & media with cross-platform integration, personalized insights, and wider reach. A new era of customer engagement is here! 📈💬 #DigitalTransformation #TechAndFinance #CustomerEn